SCHEMBL23803531

SCHEMBL23803531

CC(C)(C(=O)N(O)Cc1ccc(Cl)cc1)C(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 5/20 0.50
▸ ALDH1A1 P00352 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ MLYCD O95822 1/20 0.39
▸ PDK1 Q15118 1/20 0.39
▸ PDK2 Q15119 1/20 0.39
▸ PDK3 Q15120 1/20 0.39
▸ PDK4 Q16654 1/20 0.39
▸ CYP3A4 P08684 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ PMP22 Q01453 1/20 0.38
▸ NLRP3 Q96P20 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23803521 0.86 RIPK1 (0.68) RIPK1
SCHEMBL23803571 0.84 RIPK1 (0.50) RIPK1ALDH1A1L3MBTL1LMNA
SCHEMBL23803517 0.84 RIPK1 (0.64) RIPK1HTTRAB9AMLYCDCYP2C19
SCHEMBL23803520 0.79 RIPK1 (0.72) RIPK1ALDH1A1HTTRAB9AL3MBTL1
SCHEMBL25190333 0.77 RIPK1 (0.44) RIPK1HTTRAB9APDK1PDK2
SCHEMBL23803566 0.76 RIPK1 (0.50) RIPK1
SCHEMBL17882162 0.76 RIPK1 (0.68) RIPK1
SCHEMBL25203434 0.76 RIPK1 (0.44) RIPK1ALDH1A1HTTRAB9ACYP1A2
SCHEMBL23819641 0.75 RIPK1 (0.68) RIPK1
SCHEMBL17882167 0.73 RIPK1 (0.70) RIPK1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12129221-B2 Difluoro phenyl amide RIP1 inhibitor SIRONAX LTD (KY) 2024-10-29 — — US disclosed
EP-3883918-B1 RIP1 INHIBITORS SIRONAX LTD (KY) 2023-07-19 — — EP disclosed
CN-113272272-B RIP1 inhibitors 圣瑞诺有限公司 2023-04-07 — — CN disclosed
US-20210284598-A1 RIP1 Inhibitors SIRONAX LTD (KY) 2021-09-16 — — US disclosed
US-20210284598-A1 RIP1 Inhibitors SIRONAX LTD (KY) 2021-09-16 — — US disclosed
CN-113272272-A RIP1 inhibitors 圣瑞诺有限公司 2021-08-17 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210284598-A1 RIP1 Inhibitors RIPK1, RIPK3, RIPK4 RIPK1 1/4885ALDH1A1 3847/4885HTT 2853/4885
US-12129221-B2 Difluoro phenyl amide RIP1 inhibitor RIPK1, RIPK3, RIPK4 RIPK1 1/4885ALDH1A1 3794/4885HTT 3381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback